These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19711348)

  • 1. Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma.
    Abraham D; Zins K; Sioud M; Lucas T; Schäfer R; Stanley ER; Aharinejad S
    Int J Cancer; 2010 Mar; 126(6):1339-52. PubMed ID: 19711348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target validation using RNA interference in solid tumors.
    Aharinejad S; Sioud M; Lucas T; Abraham D
    Methods Mol Biol; 2007; 361():227-38. PubMed ID: 17172715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.
    Aharinejad S; Abraham D; Paulus P; Abri H; Hofmann M; Grossschmidt K; Schäfer R; Stanley ER; Hofbauer R
    Cancer Res; 2002 Sep; 62(18):5317-24. PubMed ID: 12235002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
    Zins K; Kovatchki D; Lucas T; Abraham D
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells.
    Chuang JH; Chuang HC; Huang CC; Wu CL; Du YY; Kung ML; Chen CH; Chen SC; Tai MH
    J Biomed Sci; 2011 Aug; 18(1):65. PubMed ID: 21861882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
    Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
    Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
    Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
    Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
    More SS; Itsara M; Yang X; Geier EG; Tadano MK; Seo Y; Vanbrocklin HF; Weiss WA; Mueller S; Haas-Kogan DA; Dubois SG; Matthay KK; Giacomini KM
    Clin Cancer Res; 2011 Apr; 17(8):2339-49. PubMed ID: 21421857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.
    Liao J; Feng W; Wang R; Ma S; Wang L; Yang X; Yang F; Lin Y; Ren Q; Zheng G
    Oncotarget; 2016 Jan; 7(2):1354-66. PubMed ID: 26595525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of primary murine stroma induced by macrophage colony-stimulating factor.
    Yamada M; Suzu S; Akaiwa E; Wakimoto N; Hatake K; Motoyoshi K; Shimamura S
    J Cell Physiol; 1997 Oct; 173(1):1-9. PubMed ID: 9326443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma.
    Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF
    Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.
    Brignole C; Marimpietri D; Di Paolo D; Perri P; Morandi F; Pastorino F; Zorzoli A; Pagnan G; Loi M; Caffa I; Erminio G; Haupt R; Gambini C; Pistoia V; Ponzoni M
    Cancer Res; 2010 Dec; 70(23):9816-26. PubMed ID: 20935225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
    Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
    In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells.
    Feduska JM; Garcia PL; Brennan SB; Bu S; Council LN; Yoon KJ
    BMC Cancer; 2013 May; 13():261. PubMed ID: 23714211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.